chr6-52189226-G-A

Variant summary

Our verdict is Benign. Variant got -15 ACMG points: 0P and 15B. BP4_StrongBP6_ModerateBP7BA1

The NM_002190.3(IL17A):​c.402G>A​(p.Arg134Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00334 in 1,614,082 control chromosomes in the GnomAD database, including 116 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.017 ( 59 hom., cov: 32)
Exomes 𝑓: 0.0019 ( 57 hom. )

Consequence

IL17A
NM_002190.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.00600
Variant links:
Genes affected
IL17A (HGNC:5981): (interleukin 17A) This gene is a member of the IL-17 receptor family which includes five members (IL-17RA-E) and the encoded protein is a proinflammatory cytokine produced by activated T cells. IL-17A-mediated downstream pathways induce the production of inflammatory molecules, chemokines, antimicrobial peptides, and remodeling proteins. The encoded protein elicits crucial impacts on host defense, cell trafficking, immune modulation, and tissue repair, with a key role in the induction of innate immune defenses. This cytokine stimulates non-hematopoietic cells and promotes chemokine production thereby attracting myeloid cells to inflammatory sites. This cytokine also regulates the activities of NF-kappaB and mitogen-activated protein kinases and can stimulate the expression of IL6 and cyclooxygenase-2 (PTGS2/COX-2), as well as enhance the production of nitric oxide (NO). IL-17A plays a pivotal role in various infectious diseases, inflammatory and autoimmune disorders, and cancer. High levels of this cytokine are associated with several chronic inflammatory diseases including rheumatoid arthritis, psoriasis and multiple sclerosis. The lung damage induced by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is to a large extent, a result of the inflammatory response promoted by cytokines such as IL17A. [provided by RefSeq, Sep 2020]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -15 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.69).
BP6
Variant 6-52189226-G-A is Benign according to our data. Variant chr6-52189226-G-A is described in ClinVar as [Benign]. Clinvar id is 771398.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-0.006 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.056 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
IL17ANM_002190.3 linkuse as main transcriptc.402G>A p.Arg134Arg synonymous_variant 3/3 ENST00000648244.1 NP_002181.1 Q16552

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
IL17AENST00000648244.1 linkuse as main transcriptc.402G>A p.Arg134Arg synonymous_variant 3/3 NM_002190.3 ENSP00000497968.1 Q16552

Frequencies

GnomAD3 genomes
AF:
0.0167
AC:
2542
AN:
152152
Hom.:
58
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0578
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00622
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.000265
Gnomad OTH
AF:
0.0148
GnomAD3 exomes
AF:
0.00452
AC:
1135
AN:
250970
Hom.:
21
AF XY:
0.00332
AC XY:
450
AN XY:
135626
show subpopulations
Gnomad AFR exome
AF:
0.0587
Gnomad AMR exome
AF:
0.00367
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000261
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000256
Gnomad OTH exome
AF:
0.00277
GnomAD4 exome
AF:
0.00194
AC:
2834
AN:
1461812
Hom.:
57
Cov.:
31
AF XY:
0.00166
AC XY:
1210
AN XY:
727204
show subpopulations
Gnomad4 AFR exome
AF:
0.0626
Gnomad4 AMR exome
AF:
0.00438
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000417
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000151
Gnomad4 OTH exome
AF:
0.00470
GnomAD4 genome
AF:
0.0168
AC:
2553
AN:
152270
Hom.:
59
Cov.:
32
AF XY:
0.0161
AC XY:
1200
AN XY:
74458
show subpopulations
Gnomad4 AFR
AF:
0.0579
Gnomad4 AMR
AF:
0.00621
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000207
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000265
Gnomad4 OTH
AF:
0.0147
Alfa
AF:
0.00813
Hom.:
12
Bravo
AF:
0.0192
Asia WGS
AF:
0.00375
AC:
13
AN:
3478
EpiCase
AF:
0.000327
EpiControl
AF:
0.000296

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJun 27, 2018- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.69
CADD
Benign
4.1
DANN
Benign
0.58

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs17880588; hg19: chr6-52054024; API